DOCSLIB.ORG

Priorclave Customer List UK and Worldwide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Priorclave Customer List UK and Worldwide 18 November 2004 Priorclave User List T.800.748.1459 | F.888.506.3650 55 East Long Lake Rd, #520 www.priorclavena.com Troy, MI 48085-4738, USA ©2011 Priorclave NA | All Rights Reserved Priorclave User List 18 November 2004 Location/Type Customer Customer Type United Kingdom South East England – Autoclaves Bedfordshire Alcontrol Laboratories Test Laboratory Binney & Smith (Europe) Ltd Chemicals/Pharmaceuticals Charles Wells Brewing Cranfield University University/Education Hazlewood Group Laboratory Food & Drink Open University University/Education Silsoe Research Institute Research Unilever Research Chemicals/Pharmaceuticals York House (Meat Products) Ltd. Food & Drink Berkshire Boehringer Ingelheim Ltd. Chemicals/Pharmaceuticals CABI Bioscience UK Centre (Ascot) Biotechnology Castrol International Chemicals/Pharmaceuticals Gillette Chemicals/Pharmaceuticals Imperial College University/Education Institute for Animal Health Research John Guest Ltd Industrial - Plastics Microscience Biotechnology NERC Centre for Population Biology Research Thames Water Utilities Water The Edward Jenner Inst for Vaccine Research Research University of Reading University/Education Vernalis Research Ltd Research Zeneca Chemicals/Pharmaceuticals Buckinghamshire Academic Century Laboratories Test Laboratory B & M Dairies Food & Drink Buckingham Foods Ltd. Food & Drink City Crown Ltd. Food & Drink Coca Cola Enterprises Ltd Food & Drink Esca Food Solutions Food & Drink Geest Prepared Foods Food & Drink Giles Foods Ltd., Food & Drink Kerry Ingredients Ltd. Food & Drink Open University University/Education University of Buckingham University/Education Essex Aventis Pharma Ltd. Chemicals/Pharmaceuticals Battelle Agrifood Ltd. Food & Drink Biotica Technology Ltd Biotechnology Cavendish Laboratories Ltd Chemicals/Pharmaceuticals Novartis Animal Vaccines Ltd. Chemicals/Pharmaceuticals Oakwood Environmental Technology Test Laboratory Priorclave User List 18 November 2004 Location/Type Customer Customer Type Schering Agrochemicals Ltd Chemicals/Pharmaceuticals Solexa Ltd Chemicals/Pharmaceuticals Unilever Bestfoods UK Food & Drink Hertfordshire Bio Products Laboratory Biotechnology CAB International Biotechnology Campden & Chorleywood Food Research Food & Drink Association DDD Ltd. Chemicals/Pharmaceuticals EMCOR Facilities Services Ltd. Test Laboratory Glaxo Group Research & Development Ltd Chemicals/Pharmaceuticals IACR Research MicroBio Group Ltd. Biotechnology Nestle Watercoolers Food & Drink NIBSC Research Pharmagene Laboratories Ltd Chemicals/Pharmaceuticals S.P.P Ltd Chemicals/Pharmaceuticals Smith Kline Beecham Chemicals/Pharmaceuticals University of Hertfordshire University/Education Kent Abbott Laboratories Ltd Chemicals/Pharmaceuticals Canterbury College University/Education Dartford & Gravesham NHS Trust Hospital DNA Research Innovations Ltd Biotechnology Dstl Research EHC Viridian Ltd. Chemicals/Pharmaceuticals Excyte Ltd Chemicals/Pharmaceuticals Ferndale Foods Food & Drink Fridays (Cranbrook) Ltd. Food & Drink Geno Var Diagnostics Ltd Chemicals/Pharmaceuticals Horticulture Research Int Agriculture Medway Maritime Hospital Hospital Pfizer Central Research Chemicals/Pharmaceuticals Quest International (F.F.F.I.) UK Ltd Food & Drink Stephens Fresh Foods Food & Drink University of Greenwich at Medway University/Education W.A Turner Ltd Food & Drink London A Nelson & Co Ltd Chemicals/Pharmaceuticals Astra Neuroscience Research Unit Chemicals/Pharmaceuticals Barts & The London University/Education Bioline Biotechnology Birkbeck College University/Education Cancer Research UK Research Charing Cross & Westminster Medical School University/Education Clinical Science Laboratories University/Education Priorclave User List 18 November 2004 Location/Type Customer Customer Type DEPM - Wolfson Institute University/Education East London University University/Education Eurofins Scientific Ltd Chemicals/Pharmaceuticals G R Micro Ltd. Test Laboratory Goddard Veterinary Group Veterinary Guy's Hospital Hospital Hammersmith & West London College University/Education Imperial College University/Education Institute of Cancer Research Research Isolagen Europe Ltd Biotechnology James Black Foundation Ltd. Research Kings College London University/Education London Hospital Hospital Ludwig Institute for Cancer Research University/Education MedPharm Ltd. Chemicals/Pharmaceuticals Middlesex University University/Education National Heart & Lung Institute Research Neals Yard Remedies Chemicals/Pharmaceuticals Newham Community College University/Education NIMR (Medical Research Council) Research Queen Mary & Westfield College University/Education Rayner & Co. Food & Drink Retroscreen Virology Ltd. Chemicals/Pharmaceuticals Richard Dimbleby Labs/Cancer Research UK Research Royal Free & University College Medical School University/Education School of Pharmacy University/Education South Bank University University/Education St Bartholomew's Hospital Hospital St. Barts & Royal London Medical School Hospital Taurus Packaging Services Ltd Food & Drink Thames Valley University University/Education The Rayne Institute University/Education UCL, Cobbold Laboratory University/Education Unigate Dairies Ltd Food & Drink Whitelands College University/Education William Harvey Research Institute Research Windeyer Institute of Medical Science Research Middlesex Arla Foods Food & Drink Brunel University University/Education Butterworth Laboratories Test Laboratory Express Foods Food & Drink Glaxo Group Research and Development Limited Chemicals/Pharmaceuticals Heathrow Airport Ltd Medical Centre Priorclave User List 18 November 2004 Location/Type Customer Customer Type Katsouris Brothers Food & Drink National Physical Laboratory Standards Laboratory Nestle UK Ltd Food & Drink Noon Products PLC Food & Drink Northwick Park APRG Hospital St Marks Hospital Hospital Veolia Water Partnership Water Surrey Abgene Biotechnology Aeon Biotech Ltd Biotechnology Agrol Ltd Agriculture B.I.B.R.A. Food & Drink Biocompatibles Ltd Biotechnology Godalming 6th Form College University/Education Greendale Laboratories Ltd Test Laboratory Guildhay Antisera Ltd. Chemicals/Pharmaceuticals Intertek Testing Services Test Laboratory M.A.F.F. Central Veterinary Laboratories Veterinary Mycoplasma Experience Ltd Biotechnology Reneuron Laboratories Biotechnology Royal Botanical Gardens Agriculture S W Thames Institute of Renal Research Research University of Kingston University/Education Veterinary Laboratories Agency Veterinary VXL Ltd Contact Lens Manufacture Wisley Gardens Agriculture Climatic Test Chambers Bedfordshire Coretec Ltd Electronics Buckinghamshire C & D Technologies Electronics Nampak PLC Packaging Essex A B Electronic Ltd Electronics Ford Motor Company Ltd Automotive Hertfordshire Loctite UK Chemical Primagraphics Ltd Electronics Kent Reliance Foundry Ltd Engineering XCEL Ltd Electronics London British Standards Institution Standards Laboratory Middlesex DRA West Drayton Defence Northrop Grumman Electronic Systems Electronics Milton Keynes H.M.Government Communications Centre Defence South England - Autoclaves Brighton & Hove MRC Cell Mutation Unit University/Education Southern Water Scientific Services Water University of Brighton University/Education Priorclave User List 18 November 2004 Location/Type Customer Customer Type Dorset Aplin & Barrett Ltd Food & Drink CEFAS Fish Diseases Laboratory Agriculture Genetix Ltd Biotechnology Hall & Woodhouse Food & Drink Superior Seals Ltd Chemicals/Pharmaceuticals Thomas Hardy Brewing Ltd Brewing East Sussex Arla Foods Food & Drink RHM Frozen Foods Ltd Food & Drink Hampshire Aspect Vision Care Contact Lens Manufacture Bacardi-Martini Ltd Food & Drink BioMerieux UK Ltd Biotechnology Coopervision/Aspect Contact Lens Manufacture Cyanamid of Great Britain Ltd Chemicals/Pharmaceuticals Hampshire Cosmetics Chemicals/Pharmaceuticals Highbury College University/Education Hydron Ltd Chemicals/Pharmaceuticals Institute of Naval Medicine Hospital Johnson & Johnson Chemicals/Pharmaceuticals King Edward VI School University/Education Oxoid Ltd Chemicals/Pharmaceuticals Pall Europe Ltd. Chemicals/Pharmaceuticals Portsmouth Water PLC Water Qinetiq Defence Ringwood Brewery Brewing Southampton General Hospital Hospital University of Portsmouth University/Education Vitacress Salads Ltd Food & Drink West Sussex Creightons Naturally Food & Drink Donnington Laboratories Ltd. Test Laboratory Profile Drug Delivery Ltd. Chemicals/Pharmaceuticals Unigate Dairies Ltd Food & Drink Chambers Hampshire Gemini Circuits Ltd Electronics Roxspur Measurement & Control Ltd. Electronics Sensit Ltd. Electronics Isle of Wight Redcliff Microsystems Electronics West Sussex Glaxo Smith Kline Chemicals/Pharmaceuticals Start Spellman Electronics South West England – Autoclaves Avon Alspac Laboratory Test Laboratory Cadbury Schweppes PLC Food & Drink Institute of Clinical Neurosciences Research Int Blood Group Ref Laboratory Research Priorclave User List 18 November 2004 Location/Type Customer Customer Type Kerry Ingredients Food & Drink Lawson Mardon Packaging Packaging Southmead Hospital Hospital University of Bristol University/Education Wessex Water PLC Water Cornwall Pall Newquay Chemicals/Pharmaceuticals Roach Foods Ltd. Food & Drink St Merryn Meat Ltd Food & Drink Westward Laboratories Food & Drink Devon Clearlab UK Ltd Test Laboratory College of St. Mark & St. John University/Education Devon Deserts Food & Drink Hazelwood Foods Food & Drink Interfish Ltd. Food & Drink Lloyd Maunder Ltd. Test Laboratory
Load more

Recommended publications
  • Specialists in Small Molecule Drug Development
    Specialists in Small Molecule Drug Development Dr Stephen Parker, Chairman Dr Tim Mitchell, CEO & Co-Founder Dr John Reader, CSO & Co-Founder Final Results for the Year Ending 30 June 2019 October 2019 www.sareum.co.uk Disclaimer The information contained in this document (“Presentation”) is directed at (i) members or creditors of a corporate body within the meaning of Article 43 of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005, as amended ("Order"), (ii) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Order, or (iii) those persons to whom it can otherwise be distributed without contravention of article 21 of the Financial Services and Markets Act 2000 (“FISMA”) or to whom it can lawfully be distributed. This Presentation has been prepared by Sareum Holdings PLC (“Company”) and provided to you for information purposes only. This Presentation is not an invitation or inducement to engage in an investment activity for the purposes of FISMA. This Presentation has not been approved by an Authorised Person (as defined in s31 FISMA), as would be required for financial promotions under s21 FISMA and, for the avoidance of doubt, is not a financial promotion for the purposes of FISMA. If, contrary to the above, this Presentation is deemed to be a financial promotion for the purposes of FISMA, the Company relies on the exemptions set out in Articles 19, 43, 59 and 69 of the Order, which exempts companies admitted to trading on relevant markets making certain communications. Please note that any indication of past performance should not be relied upon as a guide to future performance.
    [Show full text]
  • Helmdon's War Memorial Project, 2016
    Helmdon’s War Memorial The Men Behind the Names WEA Helmdon Branch November 2016 | The Men Behind the Names Contents Preface History of the War Memorial Index of Service Records (WWI unless stated otherwise) Edmund John Ayres George Victor Creed Charles Frederick Finch Arthur Oliver Franklin John Thomas Grant Alfred Humphrey Sidney Lines William Merrison William Harold Seckington Charles Arthur John Southam James Tugwood Harry Turnham William Edwin Turnham Frederick John Watson Frank Branson Watts Francis John Winmill Alfred George Humphrey (WWII) The Helmdon Roll of Honour & other Helmdon connections - William John Major - Edward Stanley Strachan Acknowledgements Appendix Memorial Dedication Service Preface Helmdon’s War Memorial - The Men Behind the Names In 2014, the 100th Anniversary of the start of the 1914 -1918 Great War, a group of Helmdon residents decided to research and publish personal details of those servicemen whose names appear on the Helmdon War Memorial. Such was their enthusiasm that the work has expanded into looking at other aspects, notably the Roll of Honour of Old Boys of Helmdon School Who Served in the First World War. First published in 2014, this 2016 update includes newly discovered facts and stories. The most relevant, up-to-date information available has been put together and can be printed off as a booklet. It is to be hoped that it will not only add to the history of Helmdon but that it will go some way to honour the great sacrifice made by those village servicemen. The authors apologise that some entries do not contain as much detail as others; available records are not always fruitful.
    [Show full text]
  • Public Session
    PUBLIC SESSION MINUTES OF ORAL EVIDENCE taken before HIGH SPEED RAIL COMMITTEE On the HIGH SPEED RAIL (LONDON – WEST MIDLANDS) BILL Tuesday, 24 February 2015 (Morning) In Committee Room 5 PRESENT: Mr Robert Syms (Chair) Sir Peter Bottomley Mr Henry Bellingham Ian Mearns Mr Michael Thornton _____________ IN ATTENDANCE: Mr Timothy Mould QC, Lead Counsel, Department for Transport Witnesses: Mr Simon Marinker, Radstone Residents Group Mr Murray Brown Mr Simon Harris Mr A. M. and Mrs R. J. Herring Mr Robert and Sally Drummond-Hay Mr Tim Smart, International Director for High Speed Rail, CH2M Hill _____________ IN PUBLIC SESSION INDEX Subject Page Radstone Residents Group Parochial Church Council for Helmdon with Stuchbury and Radstone Introduction from Mr Mould 3 Submissions from Mr Marinker 4 Mr Smart, examined by Mr Mould 17 Mr Smart, cross-examined by Mr Marinker 23 Murray Brown Submissions from Mr Brown 26 Submissions from Mr Harris 27 Submissions from Mr Mould 34 Simon Marinker Submissions from Mr Marinker 40 Mr and Mrs A Herring Submissions from Mrs Herring 44 Response from Mr Mould 49 Further submissions from Mrs Herring 53 Robert and Sally Drummond-Hay Submissions from Mr and Mrs Drummond-Hay 57 Submissions from Mr Mould 71 Closing submissions from Mr Drummond-Hay 73 Hugh Smith Submissions from Mr Smith 77 Submissions from Mr Mould 80 2 (At 9.20) 1. CHAIR: Order, order. Welcome, good morning everybody to the HS2 Select Committee. It is nice to see such a large audience of interested people. Radstone Residents Group Parochial Church Council for Helmdon with Stuchbury and Radstone 2.
    [Show full text]
  • Drug Discovery Chemistry
    Save up to $200! Final Agenda Register by February 23 COVER CHI’s 13th Annual CONFERENCE AT-A-GLANCE PLENARY KEYNOTES SHORT COURSES Drug Discovery AGENDA Plenary April 3-4 Conferences »» Protein-Protein Interactions Keynotes »» Inflammation»&»Autoimmune» Inhibitors Chemistry »» Kinase»Inhibitor»Chemistry Optimizing Small Molecules for Tomorrow's Therapeutics »» GPCR-Targeted Drug Design »» Fragment-Based»Drug» Activity-Based April 2-6, 2018 | San Diego, CA | Hilton San Diego Bayfront Discovery Proteomics: April 4-5 Conferences Protein and »» Ubiquitin»Proteasome»System» Ligand Discovery Inhibitors on a Global Scale CONFERENCE PROGRAMS »» Small»Molecules»for»Cancer» Benjamin F. Cravatt, Immunotherapy PhD, Professor and APRIL 3-4 APRIL 4-5 APRIL 6 Co-Chair, Department »» Macrocyclics»&»Constrained» of Molecular Peptides Medicine, The Protein-Protein Ubiquitin Proteasome Biophysical Approaches »» Targeting»Complex» Scripps Research Membrane»Proteins Institute Interactions System Inhibitors for Drug Discovery April 6 Symposia »» Biophysical»Approaches»for» Lead Optimization Inflammation & Small Molecules for Drug»Discovery for Drug Metabolism Autoimmune Inhibitors Cancer Immunotherapy »» Lead»Optimization»for»Drug» & Safety Metabolism»&»Safety » Targeting Ras » Blood-Brain»Penetrant» Kinase Inhibitor Macrocyclics & Blood-Brain Inhibitors and MYC for the Treatment of Chemistry Constrained Peptides Penetrant Inhibitors HOTEL & TRAVEL Cancer Stephen Fesik, SPONSORSHIP PhD, Professor GCPR-Targeted Targeting Complex Plus Short Courses & EXHIBIT
    [Show full text]
  • 2019 Analyst Day
    2019 Analyst Day March 12, 2019 NASDAQ: LGND 2 Safe Harbor Statement The following presentation contains forward-looking statements by Ligand and its partners that involve risks and uncertainties and reflect Ligand's and it’s partners’ judgment as of the date of this presentation. Words such as “plans,” “believes,” “expects,” “projects,” “could,” “anticipates,” and “will,” and similar expressions, are intended to identify forward-looking statements. These forward-looking statements include, without limitation, financial projections, expectations regarding research and development programs, potential uses of capital, including any potential dividend or share repurchase program, and the timing of the initiation or compilation of preclinical studies and clinical trials by Ligand and its partners. Actual events or results may differ from Ligand’s expectations due to risks and uncertainties inherit in Ligand’s business, including: Ligand has wide discretion on its use of capital and may choose not to engage in any share repurchases, declare any dividends or pursue acquisitions or internal develop programs; Ligand and its partners may not be able to timely or successfully advance any product(s) in its internal or partnered pipeline;, drug development program benefits may not be realized; Ligand will achieve its guidance in 2019 or thereafter; third party research summarized herein may not be correct or complete; Kyprolis®, EVOMELA® and Zulresso™ may not perform as expected, Ligand relies on collaborative partners for milestone and royalty payments,
    [Show full text]
  • Form 8-K Ligand Pharmaceuticals
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________ FORM 8-K ______________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2020 LIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter) Delaware 001-33093 77-0160744 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation or organization) Identification No.) 3911 Sorrento Valley Boulevard, Suite 110 San Diego CA 92121 (Address of principal executive offices) (Zip Code) (858) 550-7500 (Registrant’s Telephone Number, Including Area Code) N/A (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share LGND The Nasdaq Global Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    [Show full text]
  • Planning Support Statement
    PLANNING SUPPORT STATEMENT New 2FE Primary School At Radstone Fields Developed, Brackley, Northamptonshire For Northamptonshire County Council (c/o Lend Lease) Prepared by Peter Haddon and Partners Architects July 2014 • First Issue 23/07/2014 • Second Issue 10/09/2014 • Third Issue 18/11/2014 • Fourth Issue 10/01/2014 150110sp4073 A2 Planning Support Statement Radstone Fields Page 1 of 24 Contents 1 – Introduction 2 – Site Context 3 – Planning history 4 – Proposed Development 5 – Planning Policy 6 – Assessment of the Proposed Development 7 – Section 106 Agreement 8 – Mechanical Plant 9 – Conclusion 150110sp4073 A2 Planning Support Statement Radstone Fields Page 2 of 24 1. Introduction 1.1 This statement has been prepared by pHp Architects in support of a detailed planning application as the Agent of Northamptonshire County Council (NCC) (the ‘Applicant’) for the development of a 2 Form Entry Primary School and associated facilities on the Radstone Fields housing development. As the time of this report being issued a more accurate site address has not been created. 1.2 The site consists of land within the Radstone Fields housing development and will be a key building within the estate where outline planning consent has already been given for a primary school of this size. An earlier outline consent (application S/2010/0995/MAO) gave approval for existing trees, hedges and other key details to be managed or removed from site prior to the full application for the school being submitted. Construction of the housing development is currently in progress around the outside of the proposed site. 1.3 The development of the site will deliver approximately 45 (new) jobs for teaching and support staff, including cleaners, caterers and admin staff.
    [Show full text]
  • South Northamptonshire Housing and Homelessness Strategy 2015-18
    South Northamptonshire Housing and Homelessness Strategy 2015-18 1 | P a g e Portfolio Holder Introduction It is an ideal time for South Northamptonshire to re-affirm its lead role in directing and defining housing development and service delivery. While our role focuses on affordable housing; private sector housing and homelessness prevention we are also providing direction on new market development and securing our partnerships with registered providers and private sector landlords. We share a challenging environment with our partners where we must instil the confidence to be brave in the development and delivery of new products and service models when public sector resources are shrinking and there is limited central investment. This means making the most of our assets by developing new partnerships across boundaries, with the voluntary sector and in the communities where we work and deliver more integrated working. We are working in a local housing market which is meeting demand but not always need and where competition for land and funding often leads to our registered provider partners being priced out by market developers. There is unmet need for accommodation that is more expensive to deliver and more difficult for our partners to manage and unmet mental health support and community safety issues in our communities. We recognise it is not about competition between services and providers it is about presenting a single joined up service and meaning it. Thresholds for support services are going up making them more difficult to access and there is uncertainty over how the Community Wellbeing Hubs will operate and help.
    [Show full text]
  • Dashboard for the Parish of Helmdon: St Mary Magdelene W Stuchbury & Radstone: in the Deanery of BRACKLEY Parish Census and Deprivation Summary 2
    Dashboard for the parish of Helmdon: St Mary Magdelene w Stuchbury & Radstone: in the Deanery of BRACKLEY Parish census and deprivation summary 2. Worshipping Community, 2014-19 Parish population (2018): 943 1. Attendance summary, 2010-19 Parish Diocese National 500 % aged 0-17 23% 23% 21% 9 160 % aged 18-44 29% 36% 37% 8 400 140 % aged 45-64 32% 26% 25% 7 120 % aged 65 & over 16% 15% 16% 6 300 100 5 % Christian 67% 60% 59% 80 4 % non-Christian religion 1% 6% 9% 200 60 3 40 2 Parish deprivation rank (IMD, 2019): 10424 Number of people Number of people 100 Number of people 20 1 (1=most deprived parish in the Church of England, 12,382=least deprived) 0 0 0 For more detailed census & deprivation info: see http://arcg.is/1RaS4CS 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Christmas Easter age 0-17 age 18-69 https://www.churchofengland.org/researchandstats Average week, October Usual Sunday age 70+ age unspecified Joiners Leavers and http://www2.cuf.org.uk/poverty-england/poverty-map Worshipping Community Number of churches in parish (2020): 2 Parish code: 280018 3. Usual Sunday attendance, 2010-19 4. Average weekly attendance, October, 2010-19 5. Percentage children, 2010-19 Services for schools 70 100 60% identified from 2013 90 60 50% 80 40% 50 70 30% 40 60 50 20% 30 Percentage 40 10% 30 20 0% Number of people Number of people 20 10 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 10 0 0 Usual Sunday (aged <16) 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Average week, October, excluding school services (aged < 16) Adults Children Adults Children Adults, School Children, School Worshipping community (aged < 18) 6.
    [Show full text]
  • Milner Symposium 2020
    THERAPEUTICS SYMPOSIUM 2020 GLOBAL THERAPEUTIC ALLIANCE OVERVIEW A SERIES OF ONLINE EVENTS STARTING ON JUNE 12TH ALLIANCE GLOBAL THERAPEUTIC ALLIANCE The Milner Therapeutics Institute encompasses both a research institute and a global outreach programme for collaboration. GLOBAL THERAPEUTIC ALLIANCE Research in the Milner Therapeutics Institute is funded by: Our outreach programme is through the Global Therapeutic Alliance, which aims to build a global research community working together across academia and industry, with Cambridge providing a hub of expertise. The Milner Therapeutics Consortium is central to this aim (p4), and the Alliance has been expanded with the Affiliated Company p8( ) and Affiliated Institutions scheme p37( ) to bring complementary expertise and resources to the community, and provide opportunity to extend collaborative links within and beyond Cambridge. The Affiliated Venture Partnersprogramme, operational since October 2017, provides mentoring and potential funding opportunities for the Milner Therapeutics Institute and its Global Therapeutic Alliance, and especially for our in-house company accelerator Start Codon. 3 CONSORTIUM ASTEX PHARMACEUTICALS MILNER THERAPEUTICS CONSORTIUM The Milner Therapeutics Astex is a leader in innovative drug discovery and Consortium is an academic- development, committed to the fight against cancer and industry partnership, active since diseases of the central nervous system. Astex is developing June 2015. This is underpinned a proprietary pipeline of novel therapies and has multiple
    [Show full text]
  • Memory in Early Modern England
    Part II Special Subject C Memory in Early Modern England Prof. Alex Walsham ([email protected]) Overview Without memory, we could not write History. But memory itself has a history. This Special Subject investigates one segment of that history in the context of sixteenth- and seventeenth- century England. By contrast with medievalists and modernists, early modernists have been slow to investigate how the arts of remembering and forgetting were implicated in and affected by the profound religious, political, intellectual, cultural, and social upheavals of the period. However, there is now a growing surge of exciting and stimulating research on this topic. Its relevance and centrality to key historiographical debates and its capacity to shed fresh light on classic questions regarding one of the most tumultuous eras in English history are increasingly being recognised. Set against the backdrop of the profound ruptures of the Reformation, Civil Wars, and the constitutional revolution of 1688, this Paper seeks to explore how individuals and communities understood and practised memory alongside the ways in which it was exploited and harnessed, divided and fractured, by the unsettling developments through which contemporaries lived and in which they actively participated. It assesses the role played by amnesia and oblivion, nostalgia and commemoration, in facilitating change and in negotiating the legacies it left. Students will be exposed to a wide range of primary sources – from chronicles, diaries, histories, memoirs and compilations of folklore to legal depositions, pictures, maps, buildings, funeral monuments and material objects – that afford insight into the culture and transmutations of early modern memory. Sessions in the Michaelmas Term will explore contemporary perceptions and practices of memory.
    [Show full text]
  • South Northamptonshire Accommodation Guide
    www.southnorthants.gov.uk South Northamptonshire Accommodation Guide Quality Assurance and Star Ratings Index Several of the venues featured in this guide have Hotels 6 a star rating – the official mark of quality awarded to accommodation by VisitEngland and the AA. Inns with Bed and These two organisations assess accommodation Breakfast Bedrooms 9 to the same criteria and award one to five stars. What the stars mean … Bed and Breakfast H Accommodation 12 Simple, practical, no frills Self-Catering H H This guide has been produced by South Northamptonshire Council (SNC) as one of a number of initiatives to Well presented and well run encourage tourism in the district, with the active participation of the businesses mentioned. Every care has been Accommodation 18 taken by SNC to ensure that all the information contained in this document is accurate and up-to-date at the time H H H of printing and that all relevant establishments have been included. No responsibility or liability can be taken by the Good level of quality and comfort Council for any errors or omissions, or for any inconvenience caused after the guide has gone to press. Camping & Please send comments, corrections, or recommendations for other businesses that might be suitable to include Caravanning Sites 20 H H H H in a future edition of this guide to: [email protected], or to Strategic Planning and the Economy, Excellent standard throughout South Northamptonshire Council, Springfields, Towcester, Northamptonshire NN12 6AE. Map 22 January 2015/All rights reserved. H H H H H South Northamptonshire Council reserves all editorial rights.
    [Show full text]